BACKGROUND: The effects of expiratory muscle strength training (EMST) has not yet been investigated in MSA patients. OBJECTIVE: The primary objective was to test the effects of EMST on expiratory muscle strength and voluntary peak cough flow (vPCF) in patients with multiple system atrophy (MSA). The secondary objective was to assess the suitability of the pulmonary dysfunction index as a tool for identifying MSA patients with expiratory muscle weakness and reduced voluntary peak cough flow. METHODS: This was an open label, non-controlled study, with an 8-week intensive home-based EMST protocol. The outcome measures included: maximal expiratory pressure (MEP) and vPCF. The sensitivity and specificity of the index of pulmonary dysfunction in the respiratory diagnostic process were assessed using receiver operating characteristic (ROC) analysis. RESULTS: Fifteen MSA patients were enrolled in the study. Twelve MSA patients completed the training period. After the training period, MEP significantly increased (P = 0.006). Differences in vPCF were not significant (P = 0.845). ROC analysis indicated that the overall respiratory diagnostic accuracy of the index of pulmonary dysfunction had an outstanding capability to detect patients at risk of less effective coughing and an acceptable capability of detecting patients with decreased expiratory muscle strength. CONCLUSIONS: These findings indicate non-significant differences in vPCF after 8 weeks of EMST. The index of pulmonary dysfunction appears to be a promising prognostic screening tool for identifying altered cough efficacy in MSA patients. Test cut-offs may be used to select an appropriate respiratory physiotherapy technique.

Department of Neurology and Centre of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Zobrazit více v PubMed

Fanciulli A, Wenning GK. Multiple‐system atrophy. N Engl J Med 2015;372(3):249–263. PubMed

Wenning GK, Stankovic I, Vignatelli L, et al. The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 2022;37(6):1131–1148. PubMed PMC

Silber MH, Levine S. Stridor and death in multiple system atrophy. Mov Disord 2000;15(4):699–704. PubMed

Benarroch EE. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord 2007;22(2):155–161. PubMed

Wang Y, Shao W‐b, Gao L, et al. Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson's disease and multiple system atrophy–comparison with normal elderly. PLoS One 2014;9(12):e116123. PubMed PMC

Huff A, Brown A, Smith BK, Pitts TJ. Mechanisms for successful rehabilitation of cough in Parkinson's disease using expiratory muscle strength training. Perspectives of the ASHA Special Interest Groups 2017;2(13):93–102.

Papapetropoulos S, Tuchman A, Laufer D, Papatsoris AG, Papapetropoulos N, Mash DC. Causes of death in multiple system atrophy. J Neurol Neurosurg Psychiatry 2007;78(3):327–329. PubMed PMC

Cortelli P, Calandra‐Buonaura G, Benarroch EE, et al. Stridor in multiple system atrophy: consensus statement on diagnosis, prognosis, and treatment. Neurology 2019;93(14):630–639. PubMed PMC

Laciuga H, Rosenbek JC, Davenport PW, Sapienza CM. Functional outcomes associated with expiratory muscle strength training: narrative review. J Rehabil Res Dev 2014;51(4):535–546. PubMed

Reyes A, Castillo A, Castillo J, Cornejo I. The effects of respiratory muscle training on peak cough flow in patients with Parkinson's disease: a randomized controlled study. Clin Rehabil 2018;32(10):1317–1327. PubMed

Troche M, Okun M, Rosenbek J, et al. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology 2010;75(21):1912–1919. PubMed PMC

Smeltzer SC, Skurnick JH, Troiano R, Cook SD, Duran W, Lavietes MH. Respiratory function in multiple sclerosis: utility of clinical assessment of respiratory muscle function. Chest 1992;101(2):479–484. PubMed

Smeltzer SC, Lavietes MH, Troiano R, Cook SD. Testing of an index of pulmonary dysfunction in multiple sclerosis. Nurs Res 1989;38(6):370–374. PubMed

Gilman S, Wenning G, Pa L, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71(9):670–676. PubMed PMC

Wenning GK, Tison F, Seppi K, et al. Development and validation of the unified multiple system atrophy rating scale (UMSARS). Mov Disord 2004;19(12):1391–1402. PubMed

Reyes A, Castillo A, Castillo J. Effects of expiratory muscle training and air stacking on peak cough flow in individuals with Parkinson's disease. Lung 2020;198(1):207–211. PubMed

American Thoracic Society/European Respiratory Society . ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 2002;166(4):518–624. PubMed

Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319–338. PubMed

Laveneziana P, Albuquerque A, Aliverti A, et al. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J 2019;53(6):1801214. PubMed

Bott J, Blumenthal S, Buxton M, et al. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax 2009;64(Suppl 1):i1–i52. PubMed

Hamazaki N, Kamiya K, Matsuzawa R, et al. Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction. Respir Med 2020;161:105834. PubMed

Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respir Care 2009;54(10):1348–1359. PubMed

Hosmer DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. New York: Wiley; 2000.

Dimitriadis Z, Kapreli E, Konstantinidou I, Oldham J, Strimpakos N. Test/retest reliability of maximum mouth pressure measurements with the MicroRPM in healthy volunteers. Respir Care 2011;56(6):776–782. PubMed

Srp M, Capek V, Gal O, et al. Severely disabled multiple sclerosis patients can achieve the performance of healthy subjects after expiratory muscle strength training. Mult Scler Relat Disord 2021;55:103187. PubMed

Sabaté M, Rodriguez M, Méndez E, Enríques E, Gonzélez I. Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease. Arch Phys Med Rehabil 1996;77(1):29–34. PubMed

Ribeiro R, Brandão D, Noronha J, Lima C, Fregonezi G, Resqueti V, Dornelas de Andrade A. Breath‐stacking and incentive spirometry in Parkinson's disease: randomized crossover clinical trial. Respir Physiol Neurobiol 2018;255:11–16. PubMed

Fontana GA. Before we get started: what is a cough? Lung 2008;186(1):3–6. PubMed

Monteiro L, Souza‐Machado A, Valderramas S, Melo A. The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta‐analysis. Clin Ther 2012;34(5):1049–1055. PubMed

Stankovic I, Fanciulli A, Sidoroff V, Wenning GK. A review on the clinical diagnosis of multiple system atrophy. Cerebellum 2022;1–15. PubMed PMC

Srp M, Gal O, Korteova R, Jech R, Ruzicka E, Hoskovcova M. Airway clearance in patients with Parkinson's disease‐overview and possibilities of physiotherapeutic intervention. Cesk Slov Neurol N 2020;83(4):375–381.